1) La descarga del recurso depende de la página de origen
2) Para poder descargar el recurso, es necesario ser usuario registrado en Universia


Opción 1: Descargar recurso

Detalles del recurso

Descripción

Purpose: In two previous randomized trials, the adjustment of chemotherapy delivery to circadian rhythms improved tolerability and anticancer activity compared with constant-rate infusion during 5 days in patients with metastatic colorectal cancer. Patients and Methods: For this multicenter randomized trial, it was hypothesized that a chronomodulated infusion of fluorouracil, leucovorin, and oxaliplatin for 4 days (chronoFLO4) would improve survival by 10% compared with conventional 2-day delivery of the same drugs (FOLFOX2). Patients were treated every 2 weeks with intrapatient dose escalation. Results: Baseline characteristics were similar in both arms for the 564 patients (36 institutions, 10 countries). Median survival was 19.6 months (95% confidence limit [CL] 18.2, 21.2) with chronoFLO4 and 18.7 months with FOLFOX2 (95% CL 17.7, 21.0; P .55). The main dose-limiting toxicities were diarrhea for chronoFLO4 and neutropenia for FOLFOX2. The analysis of survival predictors showed that sex was the single most important factor (P .001). In women, the risk of an earlier death with chronoFLO4 was increased by 38% compared with FOLFOX2, with median survival times of 16.3 and 19.1 months (P .03), respectively. In men, the risk of death was decreased by 25% with chronoFLO4 compared with FOLFOX2, with median survival times of 21.4 and 18.3 months (P=.02), respectively. Conclusion: Both regimens achieved similar median survival times more than 18 months with an acceptable toxicity. The chronomodulated schedule produced a survival advantage over FOLFOX in men. The strong sex dependency of optimal scheduling of fluorouracil, leucovorin, and oxaliplatin calls for translational investigations of determinants related to the patient’s molecular clock.

Pertenece a

Repositório do Hospital Prof. Doutor Fernando Fonseca  

Autor(es)

Giacchetti, S -  Bjarnason, G -  Garufi, C -  Genet, D -  Iacobelli, S -  Tampellini, M -  Smaaland, R -  Focan, C -  Coudert, B -  Humblet, Y -  Canon, J -  Adenis, A -  Lo Re, G -  Carvalho, C -  Schueller, J -  Anciaux, N -  Lentz, MA -  Baron, B -  Gorlia, T -  Lévi, F - 

Id.: 54440959

Idioma: eng  - 

Versión: 1.0

Estado: Final

Palabras claveNeoplasias colorrectais - 

Tipo de recurso: article  - 

Tipo de Interactividad: Expositivo

Nivel de Interactividad: muy bajo

Audiencia: Estudiante  -  Profesor  -  Autor  - 

Estructura: Atomic

Coste: no

Copyright: sí

: openAccess

Requerimientos técnicos:  Browser: Any - 

Fecha de contribución: 26-nov-2016

Contacto:

Localización:
* J Clin Oncol. 2006 Aug 1;24(22):3562-9
* 0732-183X

Otros recursos del mismo autor(es)

  1. Optimising training data for ANNs with Genetic Algorithms International audience
  2. Hydrological model coupling with ANNs International audience
  3. Search for heavy Higgs bosons A/H decaying to a top quark pair in pp collisions at √s=8 TeV with the ATLAS detector A search for heavy pseudoscalar ( A ) and scalar ( H ) Higgs bosons decaying into a top quark pair (...
  4. Clinical Outcomes for Patients With Gleason Score 10 Prostate Adenocarcinoma: Results from a Multi-institutional Consortium Study Purpose/Objective(s): Gleason score (GS) 10 disease is the most aggressive form of clinically locali...
  5. Extremely Dose Escalated Radiation Therapy Improves Cancer-Specific Survival Compared With Radical Prostatectomy or Conventionally Dose-Escalated Radiation Therapy in Gleason Score 9-10 Prostate Adenocarcinoma: A Multi-institutional Analysis of 1403 Patie Purpose/Objective(s): To compare the outcomes of a modern cohort of patients with Gleason Score (GS)...

Aviso de cookies: Usamos cookies propias y de terceros para mejorar nuestros servicios, para análisis estadístico y para mostrarle publicidad. Si continua navegando consideramos que acepta su uso en los términos establecidos en la Política de cookies.